3 chapters across the catalog
The UK's National Health Service (NHS) has banned the routine use of puberty blockers for children with gender dysphoria, citing a lack of evidence regarding safety and effectiveness. The hosts discuss the closure of the Tavistock Clinic and compare the situation to Australia, which they claim remains heavily invested in gender-affirming medical interventions.
Gender Transition Surgery Market and NHS Policy Changes
The U.S. sex reassignment surgery market reached an estimated $1.9 billion in 2021, with female-to-male transitions showing rapid growth. In the UK, the National Health Service has announced new regional centers for children but will no longer refer children under the age of seven for gender services, citing a lack of intellectual understanding at that age.
International Shift Away from Pediatric Gender Care
While the U.S. continues to promote gender-affirming care, several European nations have performed a "180-degree turnaround." The UK's National Health Service closed the Tavistock Clinic following an independent review, and Sweden's National Board of Health now states that the risks of puberty blockers currently outweigh the benefits due to a lack of reliable scientific evidence.
